Download App

Log in to access Online Inquiry
Company Overview More
Pioneering Pharmaceutical Co., Ltd. is a new drug developer in the clinical stage, focusing on cancer drugs and other androgen receptor (AR)-related diseases. The company's main drug under research is Proclomide. The drug is in phase III clinical trials of metastatic castration-resistant prostate cancer (mCRPC) in China. The company's clinical drug under development also includes an II phase small molecule development drug Pyrilutamide, an II phase monoclonal antibody development drug ALK-1, a phase I mTOR inhibitor Detorsertib, and an hedgehog signal transduction pathway inhibitor GT1708F.
CEO: Youzhi Tong
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

09939 KINTOR PHARMA-B
22.500+0.500+2.27%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Assets
Current assets
Inventory
-- 351.36M -- 26.08M -- -- -- --
Advance deposits and other receivables
272.08% 117.66M 839.04% 141.27M 26.08% 31.62M -22.23% 15.04M
Cash and equivalents
-12.71% 930.15M -31.21% 1.23B 444.97% 1.07B 2773.66% 1.79B
Fixed time deposit-current assets
-61.33% 125.07M -- 522.41M -- 323.41M -- --
Secured deposit
-- 1.66M -- -- -- -- -- --
Total current assets
7.41% 1.53B 6.39% 1.92B 543.94% 1.42B 1461.87% 1.81B
Non-current assets
Property, plant and equipment
28.1% 223.69M 42.01% 199.42M 77.51% 174.61M 270.8% 140.42M
Intangible assets
12.33% 235.62M 16.96% 209.68M 16.99% 209.76M 0.16% 179.27M
Other illiquid assets
28.34% 44.17M -11.35% 33.17M -15.4% 34.42M 87.35% 37.42M
Special items of non-current assets
219.97% 38.61M 181.22% 36.03M -16.26% 12.07M -19.89% 12.81M
Total non-current assets
25.82% 542.09M 29.3% 478.3M 29.48% 430.86M 46.32% 369.92M
Total assets
11.69% 2.07B 10.28% 2.4B 234.58% 1.85B 490.77% 2.18B
Liabilities
Current liabilities
Accounts payable
157.79% 209.86M -50.68% 61.56M 1.76% 81.41M 147.78% 124.81M
Amounts payable to associated parties-current liabilities
-67.36% 408K -- 700K -- 1.25M -- --
Bank loans and overdrafts
-91.15% 7.4M -94.9% 5.6M 42.42% 83.6M 48.44% 109.7M
Financial lease liabilities-current liabilities
-23.74% 2.07M -34.58% 1.99M -12.09% 2.71M 0.76% 3.05M
Deferred income-current liabilities
-- -- -80.66% 100K -54.76% 361K -71.96% 517K
Total current liabilities
29.77% 219.74M -70.62% 69.95M 18.76% 169.33M 80.21% 238.08M
Net current assets
4.39% 1.31B 18.07% 1.85B 1503.59% 1.25B 9667.85% 1.57B
Total assets less current liabilities
9.87% 1.85B 20.21% 2.33B 309.49% 1.68B 720.19% 1.94B
Non-current liabilities
Long-term bank loan
9.34% 147.5M 34.11% 132.1M -- 134.9M -- 98.5M
Financial lease liabilities-non-current liabilities
464.08% 2.76M -- -- -78.8% 490K -74.77% 936K
Deferred tax liability
0% 38.82M 0% 38.82M 0% 38.82M 0% 38.82M
Deferred income-non-current liabilities
-- 4.01M -- -- -- -- -- --
Total non-current liabilities
10.84% 193.09M 23.63% 170.92M 323.56% 174.21M 225.09% 138.25M
Total liabilities
20.17% 412.83M -36% 240.87M 87% 343.54M 115.49% 376.33M
Total assets less total liabilities
9.76% 1.66B 19.95% 2.16B 307.92% 1.51B 828.79% 1.8B
Total equity and non-current liabilities
9.87% 1.85B 20.21% 2.33B 309.49% 1.68B 720.19% 1.94B
Equity
Share capital
4.6% 273K 4.6% 273K 1435.29% 261K 1640% 261K
Reserve
9.76% 1.65B 19.95% 2.16B 307.87% 1.51B 828.74% 1.8B
Legal reserve
9.76% 1.65B 19.95% 2.16B 307.87% 1.51B 828.74% 1.8B
Special items of shareholders' rights and interests
0% -17K 0% -17K -- -17K -- -17K
Shareholders' Equity
9.76% 1.66B 19.95% 2.16B 307.92% 1.51B 828.79% 1.8B
Total equity
9.76% 1.66B 19.95% 2.16B 307.92% 1.51B 828.79% 1.8B
Total equity and total liabilities
11.69% 2.07B 10.28% 2.4B 234.58% 1.85B 490.77% 2.18B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
PricewaterhouseCoopers--PricewaterhouseCoopers--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%